SCHEMBL17694334

SCHEMBL17694334

CCCCCc1ccc(-c2ccc(-c3cc(Cl)c(-c4ccc(-c5ccc(CCCCC)cc5)cc4)c4nsnc34)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ RARB P10826 10/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ RARA P10276 2/20 0.38
▸ MTOR P42345 1/20 0.38
▸ S1PR1 P21453 1/20 0.38
▸ AKR1C2 P52895 1/20 0.38
▸ AKR1C1 Q04828 1/20 0.38
▸ USP2 O75604 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17694336 0.82 KDM4E (0.48) HSD11B1KDM4ERAB9AHRH3RARB
SCHEMBL12696163 0.76 HSD11B1 (0.44) HSD11B1KDM4ERAB9ARARBHSD17B10
SCHEMBL16265324 0.74 RARB (0.52) HSD11B1KDM4ERAB9AHRH3RARB
SCHEMBL2728502 0.73 PTGS2 (0.31) —
SCHEMBL18418545 0.73 RARB (0.53) HSD11B1KDM4ERAB9ARARBHSD17B10
SCHEMBL9400075 0.72 RARB (0.49) HSD11B1KDM4EHRH3RARBHSD17B10
SCHEMBL18462921 0.72 RARB (0.42) HSD11B1KDM4ERAB9ARARBHSD17B10
SCHEMBL9399838 0.72 RARB (0.46) HSD11B1KDM4ERAB9AHRH3RARB
SCHEMBL17694326 0.71 BDKRB2 (0.40) HSD11B1KDM4ERAB9ARARBMAPT
SCHEMBL12374382 0.71 HSD11B1 (0.45) HSD11B1KDM4ERAB9ARARBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017118464-A1 LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2017-07-13 — — WO disclosed
US-20170029702-A1 LIQUID CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2017-02-02 — — US disclosed
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND MERCK PATENT GMBH (DE) 2016-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND CRY1, SLC25A1, CRY2 HSD11B1 1805/4885KDM4E 2034/4885RAB9A 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback